Association between antibodies against calcifying nanoparticles and mitral annular calcification

Journal of Heart Valve Disease

Volumn 19, Issue 6, 2010, Pages 745-752

  Candemir, Basar ^a   Ertas, Fatih Sinan ^a   Kaya, Cansin Tulunay ^a   Ozdol, Cagdas ^a   Hasan, Taner ^a   Akan, Ozay Arikan ^a   Sahin, Mustafa ^b   Erol, Cetin ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIUM ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BACTERIUM; BLOOD SAMPLING; CALCIFICATION; CALCIFYING NANOPARTICLE; CALCIFYING NANOPARTICLE INFECTION; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; DYSPNEA; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL ANNULAR CALCIFICATION; MITRAL VALVE DISEASE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENESCENCE; SENSITIVITY AND SPECIFICITY; SYNCOPE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; ANTIBODIES; BIOLOGICAL MARKERS; CALCINOSIS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART VALVE DISEASES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MITRAL VALVE; NANOPARTICLES; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TURKEY;

EID: 79551487882     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. D'Cruz I, Panetta F, Cohen H, Glick G. Submitral calcification or sclerosis in elderly patients: M-mode and two-dimensional echocardiography in mitral anulus calcification. Am J Cardiol 1979;44: 31-38
2. Hirschfeld DS, Emilson BB. Echocardiogram in calcified mitral anulus. Am J Cardiol 1975;36:354-356
3. Jeon DS, Atar S, Brasch AV, et al. Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects aged < or =65 years old. J Am Coll Cardiol 2001;38:1988-1993
4. Adler Y, Koren A, Fink N, et al. Association between mitral annulus calcification and carotid atherosclerotic disease. Stroke 1998;29:1833-1837 (Pubitemid 28399973)
5. Fox CS, Vasan RS, Parise H, et al. Framingham Heart Study. Mitral annular calcification predicts cardiovascular morbidity and mortality: The Framingham Heart Study. Circulation 2003;107:1492-1496
6. Rajamannan MN. Calcific aortic stenosis: A disease ready for prime time. Circulation 2006;114: 2007-2009
7. Miller VM, Rodgers G, Charlesworth JA, et al. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 2004;287:1115-1124
8. Kajander EO, Ciftcioglu N. Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 1998;95:8274-8279
9. Kajander EO. Nanobacteria - propagating calcifying nanoparticles. Lett Appl Microbiol 2006:42; 549-552
10. Ciftcioglu N, Bjorklund M, Kuorikoski K, Bergström K, Kajander EO. Nanobacteria: An infectious cause for kidney stone formation. Kidney Int 2000;57:1893-1898
11. Hjelle JT, Miller-Hjelle MA, Poxton IR, et al. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 2000;57:2360-2374
12. Kajander EO, Ciftcioglu N, Miller-Hjelle MA, Hjelle JT. Nanobacteria: Controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr Opin Nephrol Hypertens 2001;10:445-452
13. Sedivy R, Battistutti WB. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. Acta Pathol Microbiol Immunol Scand 2003;111:951-954
14. Puskas LG, Tiszlavicz L, Razga Z, Torday LL, Krenacs T, Papp JG. Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 2005;56:233-245
15. Ertas F, Hasan T, Akan O, et al. Anti-nanobacterial antibody titer is an independent risk factor for coronary-artery calcification [abstract]. American College of Cardiology, 55th Annual Scientific Session Exposition, Atlanta
16. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367
17. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991;84(Suppl.3):1280-1287
18. Sells S, Scully RE. Aging changes in the aortic and the mitral valves. Histologic and histochemical studies, with observations on the pathogenesis of calcific aortic stenosis and calcification of the mitral annulus. Am J Pathol 1965;46:345-365
19. Savage DD, Garrison RJ, Castelli WP, et al. Prevalence of submitral (annular) calcium and its correlates in a general population-based sample (the Framingham Study). Am J Cardiol 1983;51:1375-1378
20. Atar S, Jeon DS, Luo H, Siegel RJ. Mitral annular calcification: A marker of severe coronary artery disease in patients under 65 years old. Heart 2003;89:161-164
21. Dincer I, Ozdol C, Dandachi R, et al. Predictive value of mitral annular calcification for the diagnosis of coronary artery disease in patients with dilated cardiomyopathy. Angiology 2001;52:515-520 (Pubitemid 32777518)
22. Kizer JR, Wiebers DO, Whisnant JP, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: The Strong Heart Study. Stroke 2005;36:2533-2537
23. Kamensky G, Lisy L, Polak E, Piknova E, Plevova N. Mitral annular calcifications and aortic plaques as predictors of increased cardiovascular mortality. J Cardiol 2001;37(Suppl.1):21-26
24. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-853
25. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996;16:523-532
26. Hsu HT, Camacho NP. Isolation of calcifiable vesicles from human atherosclerotic aortas. Atherosclerosis 1999;143:353-362
27. Kim KM, Trump BF. Amorphous calcium precipitations in human aortic valve. Calcif Tissue Res 1975;18:155-160
28. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H. Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1995;15: 2003-2009
29. Tintut Y, Demer LL. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 2001;12:555-560
30. Jono S, Shioi A, Ikari Y, Nishizawa Y. Vascular calcification in chronic kidney disease. J Bone Miner Metab 2006;24:176-181
31. Glader CA, Birgander LS, Soderberg S, et al. Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J 2003;24:198-208
32. Bobryshev YV, Lord RS, Tran D. Chlamydia pneumoniae in foci of 'early' calcification of the tunica media in arteriosclerotic arteries: An incidental presence? Am J Physiol Heart Circ Physiol 2006;290:1510-1519
33. Sommer AP, McKay DS, Ciftcioglu N, Oron U, Mester A, Kajander EO. Living nanovesicles: Chemical and physical survival strategies of primordial biosystems. J Proteome Res 2003;2:441-443 (Pubitemid 36988424)
34. Folk RL. SEM imaging of bacteria and nanobacteria in carbonate sediments and rocks. J Sed Petrol 1993;63:990-999
35. Bratos-Pérez MA, Sánchez PL, García de Cruz S, et al. Association between self-replicating calcifying nanoparticles and aortic stenosis: A possible link to valve calcification. Eur Heart J 2008;29:371-376
36. Shiekh FA, Khullar M, Singh SK. Lithogenesis: Induction of renal calcifications by nanobacteria. Urol Res 2006;34:53-57
37. Wen Y, Li YG, Yang ZL, et al. Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J 2005;118:421-424
38. Hu YR, Zhao Y, Sun YW, et al. Detection of nanobacteria-like material from calcified cardiac valves with rheumatic heart disease. Cardiovasc Pathol 2009; doi: 10.1016/j.carpath.2009.06.004
39. Demer LL. Cholesterol in vascular and valvular calcification. Circulation 2001;104:1881-1883
40. Ciftcioglu N, Kajander EO. Nanobacterial growth factor. SPIE Proc 2000;3755:113-119
41. Sohshang HL, Singh MA, Singh NG, Singh SR. Biochemical and bacteriological study of urinary calculi. J Commun Dis 2000;32:216-221
42. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 2000;97:11511-11515
43. Raoult D, Drancourt M, Azza S, et al. Nanobacteria are mineralo-fetuin complexes. PLoS Pathog 2008;4:e41
44. Young JD, Martel J. The rise and fall of nanobacteria. Sci Am 2010;302:52-59
45. Wu CY, Martel J, Young D, Young JD. Fetuina/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: Demonstration of a dual inhibition-seeding concept. PLoS One 2009;4:e8058
46. Young JD, Martel J, Young D, et al. Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS One 2009;4:e5421
47. Young JD, Martel J, Young L, Wu CY, Young A, Young D. Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One 2009;4:e4417
48. Martel J, Young JD. Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci USA 2008;105:5549-5554
49. Jelic TM, Malas AM, Groves SS, et al. Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 2004;97:194-198
50. Jelic TM, Chang HH, Roque R, Malas AM, Warren SG, Sommer AP. Nanobacteria-associated calcific aortic valve stenosis. J Heart Valve Dis 2007;16: 101-105